Photo of Eli M. Miloslavsky, MD

Eli M. Miloslavsky, MD

  • Instructor in Medicine, Harvard Medical School
  • Co-Founder Vasculitis and Glomerulonephritis Center


Accepting New Patients





Clinical Interests
  • ANCA-associated vasculitis
  • Giant cell arteritis
  • Cryoglobulinemia
  • Behcet's syndrome
  • Cutaneous vasculitis
  • Aortitis
  • Dermatomyositis
  • Lupus
Medical Education
  • MD, Mount Sinai School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Internal Medicine
  • Rheumatology
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Dr. Miloslavsky's primary clinical interest is diagnosis and treatment of systemic vasculitis.  As part of the vasculitis group, he has worked extensively on a multicenter randomized trial that established rituximab as an important treatment option in ANCA-associated vasculitis (RAVE trial).  He is currently involved in several ongoing clinical trials in vasculitis that aim to improve the treatment of these conditions.

Dr. Miloslavsky also has a strong interest in medical education.  He currently teaches at MGH and Harvard Medical School where he has received several teaching awards and has published on the role of simulation and peer teaching in medical education. 

Edit Profile

Research & Publications


Miloslavsky EM, Specks U, Merkel PA et al. Rituximab for the treatment of relapses in ANCA-associated vasculitis.  Arthritis Rheumatol. 2014 Jul 21.

Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin North Am. 2014 Feb;40(1):11-26.

Miloslavsky EM, Specks U, Merkel PA et al. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2013 Sep;65(9):2441-9.

Unizony S, Arias-Urdaneta L, Miloslavsky EM et al.  Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.  Arthritis Care Res (Hoboken). 2012 Nov;64(11):1720-9.

Edit Profile


Rheumatology Associates
55 Fruit Street
Boston MA, 02114-2696
Phone: 617-726-7938

Edit Profile

Back to Top